Cite
MLA Citation
Steven Kleinman et al.. “A patient‐oriented risk–benefit analysis of pathogen‐inactivated blood components: application to apheresis platelets in the United States.” Transfusion, vol. 53, no. 7, 2013, pp. 1603–1618. http://access.bl.uk/ark:/81055/vdc_100025077110.0x000023